ImmunoPrecise Antibodies (IPA) Competitors $1.26 +0.20 (+18.58%) As of 10:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IPA vs. TLSA, TIL, OGI, CYBN, NVCT, SPRO, NLTX, IPHA, LRMR, and ALTSShould you be buying ImmunoPrecise Antibodies stock or one of its competitors? The main competitors of ImmunoPrecise Antibodies include Tiziana Life Sciences (TLSA), Instil Bio (TIL), Organigram Global (OGI), Cybin (CYBN), Nuvectis Pharma (NVCT), Spero Therapeutics (SPRO), Neoleukin Therapeutics (NLTX), Innate Pharma (IPHA), Larimar Therapeutics (LRMR), and ALT5 Sigma (ALTS). These companies are all part of the "pharmaceutical products" industry. ImmunoPrecise Antibodies vs. Its Competitors Tiziana Life Sciences Instil Bio Organigram Global Cybin Nuvectis Pharma Spero Therapeutics Neoleukin Therapeutics Innate Pharma Larimar Therapeutics ALT5 Sigma ImmunoPrecise Antibodies (NASDAQ:IPA) and Tiziana Life Sciences (NASDAQ:TLSA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership. Do analysts recommend IPA or TLSA? ImmunoPrecise Antibodies presently has a consensus price target of $4.00, suggesting a potential upside of 218.22%. Given ImmunoPrecise Antibodies' stronger consensus rating and higher possible upside, analysts plainly believe ImmunoPrecise Antibodies is more favorable than Tiziana Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ImmunoPrecise Antibodies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Tiziana Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is IPA or TLSA more profitable? Tiziana Life Sciences has a net margin of 0.00% compared to ImmunoPrecise Antibodies' net margin of -190.76%. Tiziana Life Sciences' return on equity of 0.00% beat ImmunoPrecise Antibodies' return on equity.Company Net Margins Return on Equity Return on Assets ImmunoPrecise Antibodies-190.76% -88.87% -49.26% Tiziana Life Sciences N/A N/A N/A Do insiders and institutionals hold more shares of IPA or TLSA? 6.7% of ImmunoPrecise Antibodies shares are owned by institutional investors. 6.8% of ImmunoPrecise Antibodies shares are owned by company insiders. Comparatively, 39.8% of Tiziana Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to IPA or TLSA? In the previous week, ImmunoPrecise Antibodies had 1 more articles in the media than Tiziana Life Sciences. MarketBeat recorded 1 mentions for ImmunoPrecise Antibodies and 0 mentions for Tiziana Life Sciences. ImmunoPrecise Antibodies' average media sentiment score of 1.89 equaled Tiziana Life Sciences'average media sentiment score. Company Overall Sentiment ImmunoPrecise Antibodies Very Positive Tiziana Life Sciences Very Positive Which has higher earnings & valuation, IPA or TLSA? Tiziana Life Sciences has lower revenue, but higher earnings than ImmunoPrecise Antibodies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunoPrecise Antibodies$18.16M3.17-$20.13M-$1.16-1.08Tiziana Life SciencesN/AN/A-$11.86MN/AN/A Which has more risk and volatility, IPA or TLSA? ImmunoPrecise Antibodies has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Comparatively, Tiziana Life Sciences has a beta of -0.05, suggesting that its share price is 105% less volatile than the S&P 500. SummaryImmunoPrecise Antibodies beats Tiziana Life Sciences on 7 of the 12 factors compared between the two stocks. Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IPA vs. The Competition Export to ExcelMetricImmunoPrecise AntibodiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$57.43M$1.98B$5.50B$9.00BDividend YieldN/AN/A5.39%4.10%P/E Ratio-1.0833.5026.5720.02Price / Sales3.1716.12415.46120.95Price / CashN/A55.6636.1356.90Price / Book1.358.648.065.50Net Income-$20.13M-$62.39M$3.15B$248.50M7 Day Performance13.24%0.96%1.72%2.61%1 Month Performance123.07%3.30%3.92%5.42%1 Year Performance25.70%3.97%35.02%20.76% ImmunoPrecise Antibodies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IPAImmunoPrecise Antibodies2.5375 of 5 stars$1.26+18.6%$4.00+218.2%+1.0%$57.43M$18.16M-1.0880TLSATiziana Life Sciences1.4687 of 5 stars$1.55-0.6%N/A+82.8%$182.28MN/A0.008TILInstil Bio3.4155 of 5 stars$29.84+7.7%$119.00+298.8%+137.2%$181.68MN/A-2.49410News CoverageGap UpOGIOrganigram Global1.177 of 5 stars$1.28-0.8%N/A-7.4%$172.78M$117.47M12.80860CYBNCybin2.6541 of 5 stars$7.41-4.8%$86.00+1,060.6%N/A$170.39MN/A-1.6950News CoverageNVCTNuvectis Pharma2.9632 of 5 stars$7.96-2.1%$17.00+113.6%+15.5%$169.86MN/A-7.048SPROSpero Therapeutics4.2201 of 5 stars$2.93-3.0%$5.00+70.6%+122.2%$168.85M$47.98M-2.29150NLTXNeoleukin TherapeuticsN/A$17.76-3.0%N/A-50.1%$166.91MN/A-5.7190Gap UpHigh Trading VolumeIPHAInnate Pharma3.0054 of 5 stars$1.80flat$11.00+511.1%-11.7%$165.92M$12.62M0.00220News CoverageGap DownLRMRLarimar Therapeutics1.7491 of 5 stars$2.42-6.6%$19.67+712.7%-59.7%$165.83MN/A-1.6230Gap DownHigh Trading VolumeALTSALT5 Sigma0.2102 of 5 stars$9.13-3.6%N/AN/A$165.21M$12.53M0.00170 Related Companies and Tools Related Companies Tiziana Life Sciences Alternatives Instil Bio Alternatives Organigram Global Alternatives Cybin Alternatives Nuvectis Pharma Alternatives Spero Therapeutics Alternatives Neoleukin Therapeutics Alternatives Innate Pharma Alternatives Larimar Therapeutics Alternatives ALT5 Sigma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IPA) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPA Stock Alerts